Weight-loss drugs may be covered by Medicare, Medicaid under experimental program

Weight-loss drugs may be covered by Medicare, Medicaid under experimental program

MarketWatch August 02, 2025
Upvote 0 Downvote

Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan.

Read Full Article

Comments 0

Log in to post a comment.

No comments yet. Be the first to comment!

Related News
Source Information
MarketWatch

Published on August 02, 2025

Visit Source
Advertise with Us

Reach our audience with your ads